Document Preview Unavailable

Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: post hoc analysis of phase III trials using patient-reported outcomes

Astermark Jan; Hermans Cédric; Ezzalfani Monia; Sidhom Alaeddine; Barbier Sylvaine; et al.  Therapeutic Advances in Hematology Vol. 14,  (Jan 2023).

You might have access to this document